openPR Logo
Press release

Cardiac Defibrillators Market Key Trends in terms of value Till 2020

01-12-2017 04:34 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Cardiac Defibrillators Market Key Trends in terms of value Till

Cardiac defibrillators are a component of life support systems that are used in emergency medicine for treating sudden cardiac arrests, high risk cardiac arrest patients and short term risk patients. High risk patients often suffer from life threatening diseases such as cardiac arrhythmia, ventricular fibrillation and tachycardia. Cardiac defibrillators deliver therapeutic doses of electrical current to restart sinus rhythm or normalize existing arrhythmia. These devices play a very important role in providing cardio pulmonary resuscitation or CPR to revive patients who have suffered from heart attacks. The proper use of AEDs and ALS defibrillators can save up to 700 American lives and over 50,000 lives globally that are lost due to sudden cardiac arrests. Without the use of defibrillators and CPR, the chances of survival are very low (approximately 2% to 12%) particularly in places that are away from medical facilities. The chances of survival rise drastically to over 75% when CPR and defibrillation can be given immediately.

Free Sample Report@ http://www.sa-brc.com/Global-Cardiac-Defibrillators-Market-Assessment--Forecast-2016---2020/up47

There are two major types of defibrillators; namely external defibrillators and implantable cardioverter defibrillators or ICDs. The external defibrillators market is segmented into Advanced Life Support or ALS-defibrillators and Automated External Defibrillators. ALS-defibrillators are used in hospital setting or ambulatory emergency medical services. These devices are used after basic life support intervention such as AEDs. Most ALS systems are meant to be used by professional medical personnel. The ALS defibrillators provide significantly more detailed information on patient health and status as compared to other defibrillators. Automated External Defibrillators are smaller compact devices that do not require medical professionals and can be used on patients with limited understanding. Simple instructions for applications in case of emergencies are normally provided on the casing of these devices. In recent years AEDs have been placed at public areas such as metro stations, bus stations, parks, office spaces and academic institutions for emergencies. People are now often trained in using these automated external defibrillators for such instances. Implantable cardioverter defibrillators are placed under the skin. ICDs are intended for patients who have had episodes or are at high risk for experiencing life-threatening ventricular tachycardia (VT) or ventricular fibrillation (VF) that can lead to death. The devices are implanted using minimally invasive procedure and comprise of a small charge generator with leads placed near the heart muscles.

Click For Request TOC@ http://www.sa-brc.com/Global-Cardiac-Defibrillators-Market-Assessment--Forecast-2016---2020/upcomingdetail47

The market for external cardiac defibrillators is anticipated to remain stable with a modest growth of 7.8%. The market for implantable defibrillators on the other hand continues to face technological hurdles. In 2016, St. Jude Medical initiated recall of some ICD models due to risk of premature battery depletion, a condition linked to two deaths in Europe. In 2015, Medtronic had to recall three models of InSyncIII due unexpected power failure in the pacemaker. The overall cardiac defibrillators market is anticipated to develop greater due to increasing cardiovascular and cardiac incidences. Key players in the market include Physio-Control, HeartSine, Philips, DefibTech, Cardiac Science and Zoll Medical. Zoll medical has initiated into innovative defib- apparel that is anticipated to become in popular demand in the years ahead paving a way for wearable life support systems market.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Defibrillators Market Key Trends in terms of value Till 2020 here

News-ID: 411343 • Views: 381

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for Cardiac

Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Ambulatory Cardiac Monitoring Devices
Ambulatory Cardiac Monitoring Devices Market by Product (Ambulatory Rhythm Monitor, Ambulatory ECG Monitor, Ambulatory Cardiac Event Monitor, Implantable Loop Recorder, Ambulatory real-time Cardiac Monitors, Cardiac Output Monitors); by End-User (Hospitals, Ambulatory Care Centers); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) –
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are